Arbutus Biopharma Corp
$4.74
The Read: Arbutus Biopharma’s final procedural catalysts, including patent litigation verdicts and oral hearings, have historically triggered median absolute stock moves of about 5%.
Price
Overlays
Panel
ABUS
Hover to view data
No Data